Table 1 (a) Associations for rs7741021 in the RSPO3 locus (C-allele = effect allele). (b) Associations for rs3734626 in the RSPO3 locus (T-allele = effect allele). (c) Associations for rs2489623 in the RSPO3 locus (C-allele = effect allele).
From: RSPO3 is important for trabecular bone and fracture risk in mice and humans
Trait | EAF | OR | 95% CI | P -value | No. of cases | No. of controls | Source |
---|---|---|---|---|---|---|---|
(a) | |||||||
Fractures | |||||||
Fracture at any bone site | 0.47 | 0.95 | (0.94–0.96) | 8.9E−65 | 421,084 | 737,530 | |
Distal forearm fractures | 0.48 | 0.88 | (0.86–0.91) | 9.6E−14 | 7,324 | 431,432 | New analyses in UK Biobank |
Hip fractures | 0.48 | 0.94 | (0.90–0.98) | 4.4E−03 | 4,035 | 434,902 | New analyses in UK Biobank |
Bone parameters | EAF | Beta | SE | P-value | No. of total | Source | |
eBMD | 0.48 | 0.079 | 0.002 | 5.6E−336 | 426,824 | Morris et al. 8 | |
Trabecular vBMD | 0.48 | 0.088 | 0.028 | 1.4E−03 | 2,500 | Paternoster et al. 34 | |
Cortical vBMD | 0.48 | −0.013 | 0.015 | 4.1E−01 | 5,878 | Paternoster et al. 34 | |
Cortical thickness | 0.48 | 0.012 | 0.017 | 4.8E−01 | 5,878 | Zheng et al. 9 | |
eQTL | EAF | Beta | SE | P value | No. of total | Source | |
RSPO3 mRNA in adipose tissue | 0.44 | 0.15* | 2.4E−04 | 581 | GTEx portal | ||
RSPO3 mRNA in fibroblasts | 0.46 | 0.12* | 1.8E−04 | 483 | GTEx portal |
(b) | |||||||
Fractures | |||||||
Fracture at any bone site | 0.53 | 0.94 | (0.93–0.95) | 1.8E−20 | 53,184 | 426,795 | Morris et al. 8 |
Distal forearm fractures | 0.52 | 0.89 | (0.86–0.92) | 2.4E−12 | 7,324 | 431,432 | New analyses in UK Biobank |
Hip fractures | 0.52 | 0.95 | (0.91–0.99) | 1.4E−02 | 4,035 | 434,902 | New analyses in UK Biobank |
Bone parameters | EAF | Beta | SE | P value | No. of total | Source | |
eBMD | 0.53 | 0.069 | 0.002 | 1.9E−258 | 426,824 | Morris et al. 8 | |
Trabecular vBMD | 0.51 | 0.092 | 0.028 | 9.4E−04 | 2,500 | Paternoster et al. 34 | |
Cortical vBMD | 0.52 | −0.010 | 0.015 | 5.0E−01 | 5,878 | Paternoster et al. 34 | |
Cortical thickness | 0.52 | 0.015 | 0.017 | 3.7E−01 | 5,878 | Zheng et al. 9 | |
cis-pQTL | EAF | Beta | SE | P value | No. of total | Source | |
Circulating RSPO3 | 0.56 | 0.325 | 0.023 | 1.8E−45 | 3,200 |
(c) | |||||||
Fractures | |||||||
Fracture at any bone site | 0.54 | 0.95 | (0.94–0.96) | 1.0E−14 | 53,184 | 426,795 | Morris et al. 8 |
Distal forearm fractures | 0.53 | 0.89 | (0.86–0.92) | 8.5E–13 | 7,324 | 431,432 | New analyses in UK Biobank |
Hip fractures | 0.53 | 0.96 | (0.92–1.01) | 1.1E–01 | 4,035 | 434,902 | New analyses in UK Biobank |
Bone parameters | EAF | Beta | SE | P value | No. of total | Source | |
eBMD | 0.54 | 0.061 | 0.002 | 6.6E−205 | 426,824 | Morris et al. 8 | |
Trabecular vBMD | 0.53 | 0.084 | 0.028 | 2.4E−03 | 2,500 | Paternoster et al. 34 | |
Cortical vBMD | 0.53 | 0.020 | 0.015 | 2.0E−01 | 5,878 | Paternoster et al. 34 | |
Cortical thickness | 0.53 | 0.016 | 0.017 | 3.5E−01 | 5,878 | Zheng et al. 9 | |
cis-pQTL | EAF | Beta | SE | P value | No. of total | Source | |
RSPO3 | 0.53 | 0.270 | 0.025 | 3.6E−28 | 3,301 |